Sign in

CIK 0001858848

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Tenaya Therapeutics, Inc.

Sign in to watch
Ticker
TNYA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
813789973
Phone
+1 415-865-2066
Business address
171 OYSTER POINT BLVD., SUITE 500, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2023-02-15 Tingley Whittemore Chief Medical Officer Grant or award +35,000 35,000
2023-02-15 Tingley Whittemore Chief Medical Officer Grant or award +45,000 80,000
2023-02-15 Tingley Whittemore Chief Medical Officer Grant or award · Stock Option (Right to buy) +205,000 205,000
2023-02-15 PATTERSON LEONE D Chief Fin. and Bus. Officer Grant or award +30,000 32,000
2023-02-15 PATTERSON LEONE D Chief Fin. and Bus. Officer Grant or award +35,000 67,000
2023-02-15 PATTERSON LEONE D Chief Fin. and Bus. Officer Grant or award · Stock Option (Right to buy) +190,000 190,000
2023-02-15 Ali Faraz Chief Executive Officer Grant or award +125,000 125,000
2023-02-15 Ali Faraz Chief Executive Officer Grant or award · Stock Option (Right to buy) +675,000 675,000
2023-02-08 COLUMN GROUP III GP, LP 10% owner Purchase +1,500,000 $2.60 $3.9M 11,370,274
2023-02-08 GOEDDEL DAVID V Director Purchase +1,500,000 $2.60 $3.9M 11,370,274
2023-01-19 COLUMN GROUP III GP, LP 10% owner Purchase +69,739 $2.50 $174K 9,870,274
2023-01-19 GOEDDEL DAVID V Director Purchase +69,739 $2.50 $174K 9,870,274
2023-01-18 COLUMN GROUP III GP, LP 10% owner Purchase +135,688 $2.52 $341K 9,800,535
2023-01-18 GOEDDEL DAVID V Director Purchase +135,688 $2.52 $341K 9,800,535
2023-01-17 COLUMN GROUP III GP, LP 10% owner Purchase +49,463 $2.49 $123K 9,664,847
2023-01-17 GOEDDEL DAVID V Director Purchase +49,463 $2.49 $123K 9,664,847
2022-12-05 Burroughs Amy L. Director Grant or award · Stock Option (Right to buy) +40,000 40,000
2022-11-21 Srivastava Deepak Director Purchase +230,769 $2.60 $600K 372,435
2022-11-21 COLUMN GROUP III GP, LP 10% owner Purchase +9,615,384 $2.60 $25.0M 9,615,384
2022-11-21 GOEDDEL DAVID V Director Purchase +9,615,384 $2.60 $25.0M 9,615,384

Page 9 of 12 · 228 trades